Publicaciones en colaboración con investigadores/as de University of Cologne (10)

2024

  1. In vitro activity of ozenoxacin against Staphylococcus aureus and Streptococcus pyogenes clinical isolates recovered in a worldwide multicentre study (2020-2022)

    JAC-Antimicrobial Resistance, Vol. 6, Núm. 3

2022

  1. Multicenter, Prospective Validation of a Phenotypic Algorithm to Guide Carbapenemase Testing in Carbapenem-Resistant Pseudomonas aeruginosa Using the ERACE-PA Global Surveillance Program

    Open Forum Infectious Diseases, Vol. 9, Núm. 2

2021

  1. Elevated MICs of susceptible antipseudomonal cephalosporins in non-carbapenemase-producing, carbapenem-resistant pseudomonas aeruginosa: Implications for dose optimization

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 11

  2. The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 12, pp. 2533-2541

2017

  1. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study

    The Lancet Infectious Diseases, Vol. 17, Núm. 2, pp. 153-163

2016

  1. Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countries

    Clinical Microbiology and Infection, Vol. 22, Núm. 1, pp. 63.e1-63.e5

2015

  1. In vitro activity of ceftazidime, ceftaroline and aztreonam alone and in combination with avibactam against European Gram-negative and Gram-positive clinical isolates

    International Journal of Antimicrobial Agents, Vol. 45, Núm. 6, pp. 641-646

2013

  1. Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in 2011

    Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 1, pp. 164-167

  2. Carbapenemase-producing Enterobacteriaceae in Europe: A survey among national experts from 39 countries, February 2013

    Eurosurveillance, Vol. 18, Núm. 28

2012

  1. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

    Clinical Microbiology and Infection, Vol. 18, Núm. 5, pp. 413-431